Methylphenidate and Xolair drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methylphenidate (methylphenidate) and Xolair (omalizumab). Common drug interactions include cystitis among females and genital infection male among males.

The phase IV clinical study analyzes what interactions people have when they take Methylphenidate and Xolair. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Methylphenidate?

Methylphenidate has active ingredients of methylphenidate. eHealthMe is studying from 8,216 Methylphenidate users. Check the latest studies of Methylphenidate.

What is Xolair?

Xolair has active ingredients of omalizumab. It is often used in asthma. eHealthMe is studying from 77,554 Xolair users. Check the latest studies of Xolair.

On Jul, 14, 2026

42 people who take Methylphenidate and Xolair together, and have interactions are studied.

Methylphenidate and Xolair drug interactions.

What are the common drug interactions of Methylphenidate and Xolair, by gender? *:

female:

Cystitis (inflammation of the wall of the bladder)
Drug ineffective
Fall
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Pericarditis (inflammation of the pericardium)
Spinal fracture (fracture in one of vertebrae)
Catheter site urticaria
Concussion (short loss of normal brain function in response to a head injury)
Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
Gastrointestinal disorder (functional problems of gastrointestinal tract)

male:

Genital infection male
Anaphylactic reaction (serious allergic reaction)
Hypersensitivity
Influenza
Insomnia (sleeplessness)
Lacrimation increased
Malaise (a feeling of general discomfort or uneasiness)
Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
Orchitis noninfective (non infectious inflammation of the testes)
Panic attack

What are the common drug interactions of Methylphenidate and Xolair, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Pulmonary embolism (blockage of the main artery of the lung)

20-29:

Pyrexia (fever)
Rash
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose)
Rhinorrhoea (watery mucus discharge from the nose)
Skin lesion
Somnambulism (sleep walking)
Sputum discoloured
Testicular pain (pain in testes)
Anaphylactic reaction (serious allergic reaction)
Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)

30-39:

Weight decreased
Back pain
Blood pressure increased
Borderline personality disorder
Chest pain
Coeliac disease (simple food intolerance)
Cough
Dehydration (dryness resulting from the removal of water)
Fatigue (feeling of tiredness)
Fibromyalgia (a long-term condition which causes pain all over the body)

40-49:

Anxiety
Chronic kidney disease
Renal failure (kidney dysfunction)
Renal injury (kidney injury)

50-59:

Cerebral haemorrhage (bleeding within the brain)
Anxiety
Nightmare (unpleasant dream)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Urticaria (rash of round, red welts on the skin that itch intensely)
Hypersensitivity
Sneezing
Eye disorder

60+:

Multiple allergies (allergy to multiple agents)
Seasonal allergy (allergic condition due to certain season)
Upper respiratory tract infection
Gastrointestinal bacterial infection (infection of the stomach and intestines caused by bacteria)
Hypersensitivity
Pruritus (severe itching of the skin)
Pulmonary congestion (congestion in the lungs)
Rash
Sleep disorder
Sleep disorder due to a general medical condition

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 12 people, 28.57%
Idiopathic Urticaria (allergic reactions, presence of hives with unknown cause): 10 people, 23.81%
Immunodeficiency Common Variable: 8 people, 19.05%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Methylphenidate and Xolair?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously